1.26

6.67% -0.09

After Hours: 1.24 -0.02 -1.59%

Mainz Biomed N V (MYNZ)

Overview News Price History Why MYNZ Down? Discussions Forecast

Mainz Biomed N V stock is traded at $1.26, with a volume of 685.23K. It is down -6.67% in the last 24 hours and up +8.62% over the past month. Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Previous Close:

$1.35

Open:

$1.39

24h Volume:

685.23K

Relative Volume:

1.22

Market Cap:

$11.42M

Revenue:

$895.50K

Net Income/Loss:

$-26.30M

P/E Ratio:

-0.0192

EPS:

-65.5728

Net Cash Flow:

$-23.84M

1W Performance:

+12.50%

1M Performance:

+8.62%

6M Performance:

-10.00%

1Y Performance:

-73.02%

1-Day Range:

$1.12

$1.39

1-Week Range:

$1.08

$1.50

52-Week Range:

$0.92

$8.20

Mainz Biomed N V Stock (MYNZ) Company Profile

Name

Mainz Biomed N V

Sector

Healthcare (1116)

Industry

Diagnostics & Research (54)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

MYNZ's Discussions on Twitter

Compare MYNZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MYNZ Mainz Biomed N V	1.26	12.23M	895.50K	-26.30M	-23.84M	-65.57
TMO Thermo Fisher Scientific Inc	617.15	233.21B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	235.57	167.12B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	714.55	56.44B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	147.81	41.84B	6.95B	1.30B	1.15B	4.5696
IQV Iqvia Holdings Inc	244.29	40.96B	15.90B	1.28B	2.21B	7.2842

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-25	Initiated	Maxim Group	Buy
Nov-25-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-21-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-21-22	Initiated	H.C. Wainwright	Buy

Mainz Biomed N V Stock (MYNZ) Latest News

11:22 AM

How strong is Mainz Biomed N.V. stock revenue growthMarket Sentiment Indicators & Big Gains Small Capital - ulpravda.ru

11:22 AM

Jan 06, 2026

Retail Trends: Will Mainz Biomed NV stock see PE expansionWeekly Profit Analysis & Safe Capital Growth Tips - moha.gov.vn

Jan 06, 2026

Jan 05, 2026

Mainz Biomed Provides Review of 2025 Highlights - GlobeNewswire

Jan 05, 2026

Jan 02, 2026

Earnings Risk: Why analysts upgrade Pony AI Inc Depositary Receipt stock2025 Short Interest & Weekly Consistent Profit Watchlists - moha.gov.vn

Jan 02, 2026

Dec 31, 2025

Is Mainz Biomed NV a good long term investmentBullish Engulfing Patterns & Insights From Wall Street Professionals - earlytimes.in

Dec 31, 2025

Dec 29, 2025

Form 424B5 MAINZ BIOMED N.V. - StreetInsider

Dec 29, 2025

Dec 27, 2025

Mainz Biomed (NASDAQ:MYNZ) Upgraded by Wall Street Zen to Hold Rating - Defense World

Dec 27, 2025

Dec 24, 2025

Mainz Biomed (NASDAQ:MYNZ) Stock Price Up 2.7% – Still a Buy? - Defense World

Dec 24, 2025

Dec 20, 2025

Why retail investors favor Mainz Biomed N.V. stockSwing Trade & Fast Gaining Stock Strategy Reports - Улправда

Dec 20, 2025

Dec 19, 2025

Why Mainz Biomed N.V. (4TO) stock is a strong buy callJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда

Dec 19, 2025

Why Mainz Biomed N.V. stock remains undervalued2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда

Dec 19, 2025

Will Mainz Biomed N.V. stock reach all time highs in 20252025 Year in Review & Weekly Watchlist of Top Performers - Улправда

Dec 19, 2025

How Mainz Biomed N.V. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Momentum Watchlists - ulpravda.ru

Dec 19, 2025

Dec 18, 2025

Is Mainz Biomed N.V. stock a buy for dividend growthJuly 2025 Movers & Reliable Intraday Trade Alerts - Улправда

Dec 18, 2025

Dec 12, 2025

Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser

Dec 05, 2025

Mainz Biomed (Nasdaq: MYNZ) targets $150M shelf to advance cancer diagnostics - Stock Titan

Dec 05, 2025

Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser

Dec 05, 2025

Dec 04, 2025

Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser

Dec 04, 2025

Dec 03, 2025

Is Mainz Biomed N.V. (4TO) stock expanding market penetrationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser

Dec 03, 2025

DoctorBox Adds Mainz Biomed's ColoAlert to Its Portfolio - marketscreener.com

Dec 03, 2025

Why Mainz Biomed N.V. (4TO) stock is favored by hedge fundsProduct Launch & Weekly High Conviction Ideas - Newser

Dec 03, 2025

Dec 02, 2025

Mainz Biomed (MYNZ) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio - GlobeNewswire

Dec 02, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio - TradingView — Track All Markets

Dec 02, 2025

Nov 29, 2025

Weekly Trades: Why hedge funds are buying Mainz Biomed N.V. stockJobs Report & Reliable Price Breakout Alerts - moha.gov.vn

Nov 29, 2025

Nov 27, 2025